|
Sign In to gain access to subscriptions and/or personal tools.
|
Patterns of Antipsychotic and Anticholinergic Prescribing for Hospital Inpatients
Carol Paton
Oxleas NHS Trust, Pinewood House, Dartford, Kent, UK.
Richard Duffett
Maria Harrington
Paul Lelliott
Royal College of Psychiatrists Research Unit, London, UK.
Chike Okocha
Oxleas NHS Trust, Queen Elizabeth Hospital, Woolwich, London, UK.
Tom Sensky
Imperial College School of Medicine, West Middlesex University Hospital, Isleworth, Middlesex, UK.
The development of atypical antipsychotics has not only given the prescriber more options, but also increased the complexity of decision making. We examined current prescribing practice for antipsychotic and anticholinergic drugs, which involved a 1-day census of all antipsychotic and anticholinergic drugs prescribed for 4191 inpatients in 49 UK mental health services. Eighty-five percent of inpatients were prescribed antipsychotics, 48% of whom were prescribed more than one. Atypical antipsychotics were widely prescribed and combined with typicals in over 60% of cases. Large doses of antipsychotics were frequently prescribed `as required'. The dose administered was always much less than the dose prescribed and nothing at all was administered against 79% of prescriptions. Antipsychotic prescribing often deviates from recommended practice. Nursing staff have considerable discretion to administer large doses of antipsychotics on an `as required' basis.
Key Words: antipsychotic census dose high dose polypharmacy prescribing practice
Journal of Psychopharmacology, Vol. 17, No. 2,
223-229 (2003)
DOI: 10.1177/0269881103017002012

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Haddad, M. Taylor, and O. S. Niaz
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
The British Journal of Psychiatry,
November 1, 2009;
195(52):
S20 - S28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. E. Barnes, A. Shingleton-Smith, and C. Paton
Antipsychotic long-acting injections: prescribing practice in the UK
The British Journal of Psychiatry,
November 1, 2009;
195(52):
S37 - S42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Paton, T. R. E. Barnes, M.-R. Cavanagh, D. Taylor, P. Lelliott, and the POMH-UK project team
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing
The British Journal of Psychiatry,
June 1, 2008;
192(6):
435 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ahmed, D. N Osser, C. M Boisvert, L. G Albert, and M. Aslam
Rationale for Emphasis on Management over Treatment of Schizophrenia in Clinical Practice
Ann. Pharmacother.,
April 1, 2007;
41(4):
693 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Honer, A. E. Thornton, E. Y.H. Chen, R. C.K. Chan, J. O.Y. Wong, A. Bergmann, P. Falkai, E. Pomarol-Clotet, P. J. McKenna, E. Stip, et al.
Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia
N. Engl. J. Med.,
February 2, 2006;
354(5):
472 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Conley, D. L. Kelly, T. J. Lambert, and R. C. Love
Comparison of Clozapine Use in Maryland and in Victoria, Australia
Psychiatr Serv,
March 1, 2005;
56(3):
320 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|